Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Mobilization”

194 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 194 results

Testing effectiveness (Phase 2)Study completedNCT01225419
What this trial is testing

Mobilization by Plerixafor of Haematopoietic Stem Cells in Children

Who this might be right for
Children Cancer, Solid Tumor
University Hospital, Clermont-Ferrand 5
Early research (Phase 1)Not Yet RecruitingNCT07254793
What this trial is testing

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

Who this might be right for
Acute Lymphoid LeukemiaAcute Myeloid LeukemiaAcute Undifferentiated Leukemia (AUL)+3 more
University of Arizona 94
Testing effectiveness (Phase 2)Study completedNCT01220375
What this trial is testing

PAV-trial: Plerixafor and Chemotherapy With Vinorelbine for Stem Cell Mobilization in Patients With Myeloma

Who this might be right for
Myeloma
Insel Gruppe AG, University Hospital Bern 44
Testing effectiveness (Phase 2)Study completedNCT00075335
What this trial is testing

AMD 3100 (Mozobil Plerixafor) to Mobilize Stem Cells for Donation

Who this might be right for
Healthy
National Heart, Lung, and Blood Institute (NHLBI) 8
Early research (Phase 1)Study completedNCT01841476
What this trial is testing

Safety and Efficacy of POL6326 for Mobilization of Hematopoietic Stem Cells in Healthy Volunteers

Who this might be right for
Healthy
Polyphor Ltd. 27
Large-scale testing (Phase 3)Study completedNCT01767714
What this trial is testing

Evaluation of Plerixafor Plus G-CSF to Mobilize and Collect 5×10^6CD34+ Cells/kg in Non-Hodgkin's Lymphoma (NHL) Patients for Autologous Transplantation

Who this might be right for
Non-Hodgkin's Lymphoma
Sanofi 100
Testing effectiveness (Phase 2)Ended earlyNCT00396383
What this trial is testing

Treatment With AMD3100 (Plerixafor) in MM Patients to Mobilize PBCs For Collection and for Transplantation

Who this might be right for
Multiple Myeloma
Genzyme, a Sanofi Company 9
Early research (Phase 1)Study completedNCT02073019
What this trial is testing

A Phase I Study Evaluating Safety, Tolerability, PK and PD of BL-8040 for Stem Cell Mobilization in Healthy Volunteers

Who this might be right for
Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB)
BioLineRx, Ltd. 33
Testing effectiveness (Phase 2)UnknownNCT02083718
What this trial is testing

Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function

Who this might be right for
Stem Cell Transplantation, HematopoieticPoor Graft FunctionHematological Diseases
Nanfang Hospital, Southern Medical University 120
Testing effectiveness (Phase 2)Ended earlyNCT02983097
What this trial is testing

Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma Grade III (FL III°)Mantle Cell Lymphoma (MCL), Blastoid Variant+2 more
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 34
Testing effectiveness (Phase 2)UnknownNCT00061568
What this trial is testing

Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias

Who this might be right for
Congenital Hemolytic AnemiaSickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI) 130
Large-scale testing (Phase 3)Looking for participantsNCT06514508
What this trial is testing

Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Guangzhou Gloria Biosciences Co., Ltd. 60
Large-scale testing (Phase 3)UnknownNCT02240992
What this trial is testing

MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment

Who this might be right for
Stem Cell Transplantation, HematopoieticPoor Graft FunctionDelayed Platelet Engraftment+1 more
Nanfang Hospital, Southern Medical University 120
Testing effectiveness (Phase 2)Study completedNCT01458288
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease

Who this might be right for
Multiple MyelomaNon-hodgkin's LymphomaHodgkin's Disease
GPCR Therapeutics, Inc. 12
Not applicableStudy completedNCT01738373
What this trial is testing

Registry of Patients Treated With Plerixafor (Mozobil®) for Haematopoietic Stem Cell Mobilization Before Autologous Transplantation

Who this might be right for
Bone Marrow / Autologous Transplants
Genzyme, a Sanofi Company 262
Not applicableStudy completedNCT00293384
What this trial is testing

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Barbara Ann Karmanos Cancer Institute 40
Early research (Phase 1)Active Not RecruitingNCT03664830
What this trial is testing

Safety of Blood Stem Cell Mobilization With Plerixafor in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
City of Hope Medical Center 5
Testing effectiveness (Phase 2)Ended earlyNCT01182675
What this trial is testing

Hematopoietic Stem Cell Transplantation (HSCT) for Children With SCID Utilizing Alemtuzumab, Plerixafor & Filgrastim

Who this might be right for
Severe Combined Immunodeficiency
University of California, San Francisco 7
Post-approval studies (Phase 4)Study completedNCT00536887
What this trial is testing

Effects of Atorvastatin 10 mg Versus 40 mg in Eight Months Follow-up Coronary Flow Reserve and Bone Marrow Stem Cell Mobilization in Patients With Acute Myocardial Infarction

Who this might be right for
Acute Myocardial Infarction
Korea University Anam Hospital 100
Early research (Phase 1)Study completedNCT06547112
What this trial is testing

A Pharmacodynamic Study of the Apheresis Product of Multiple Myeloma Patients Undergoing Quad-induction Followed by Motixafortide + G-CSF Mobilization

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 20
Load More Results